Tuesday, March 19, 2019
Category : NEWS, TRAINING | Author : experts | Comment : No Comments

Sorry, this entry is only available in French.

NOL, Nutraveris Online, the most efficient data solution to create, keep up-to-date and launch your products in the 28 EU member states, used for 10years by more than 500 industry leaders informs you:


Red yeast rice has been suspected to induce some toxicological side effects. The aim of this systematic review and meta-analysis was to examine the available scientific evidences on the safety of red yeast rice supplementations. Data were pooled from 53 randomized and controlled trial, for a total of 8535 subjects (5537 supplemented with red yeast rice and 4303 controls).

Red yeast rice

Results showed that red yeast rice was not associated with increased risk of musculoskeletal disorders (OR = 0.94, 95% CI: 0.53-1.65). In addition, reduced risk of non-skeletal musculoskeletal adverse events (OR = 0.59, 95% CI: 0.50-0.69) and serious adverse events (OR = 0.54, 95% CI: 0.46-0.64) have been measured with red yeast rice in comparison to control. Furthermore, increasing the doses of monacolin K was negatively associated with increasing risk of non-skeletal musculoskeletal adverse events.


In conclusion, this large meta-analysis demonstrate that the use of red yeast rice as hypocholesterolemic supplement is not associated with safety concern.



Fogacci F, Banach M, Mikhailidis DP, Bruckert E, Toth PP, Watts GF, Reiner Ž, Mancini J, Rizzo M, Mitchenko O, Pella D, Fras Z, Sahebkar A, Vrablik M, Cicero AFG; Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group the International Lipid Expert Panel (ILEP). SAFETY OF RED YEAST RICE SUPPLEMENTATION: A SYSTEMATIC REVIEW AND META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS. Pharmacol Res. 2019 Mar 4. pii: S1043-6618(19)30317-2.


This information has been sourced by NOL, a collaborative and complete tool which contains all Regulatory, Scientific and Marketing data

  • It solves all regulatory issues since it contains the required information on all ingredients authorized in the 28 European member states…on regulatory status, health claims, authority opinions
  • It protects your investments since it is updated in real time with reliable quality information analyzed and reviewed by our experts, available hotline.
  • It enables you to be the most responsive with monthly reports and live alerts and a personal use of the information with a report editing tool and customizable bookmarks.

With NOL let’s : 

  • Formulate new innovative products
  • Check if your already existing formulas are still compliant with the in force regulations
  • Adapt your existing formulas to the requirements of other European countries where you are willing to export them
  • Do scientific & regulatory & marketing monitoring which enable to anticipate the withdrawal of products, the safety issues, new interesting scientific studies, the arrival of new players on the market…


More information on

Contact our Scientific & Regulatory experts at NUTRAVERIS, +33 2 96 76 54 87